Effect of montelukast on hepatic and renal ischemia/reperfusion injury

Year 2017, Volume: 8 Issue: 2, 43 - 51, 18.06.2017

Ali Baran Budak Kemal Korkmaz Hikmet Selçuk Gedik Gökhan Lafçı Ertuğrul Kaya Handan Ankaralı Serdar Günaydın

https://doi.org/10.18663/tjcl.304530

Abstract

Aim: The thoracoabdominal aortic
aneurysm surgery may cause splanchnic ischemia and may result in severe
postoperative complications caused by liver and/or kidney injury. This study
investigated the effect of temporary occlusion of the aorta on the development
of I/R injury of liver and kidney and the protective effect of montelukast, a
selective reverse CysLT1 receptor antagosit.

 Material and Methods: Twenty-one male Sprague-Dawley
rats were randomly assigned to three groups (n=7 per group) as G1 (no aortic
occlusion and montelukast administration), G2 (45 min. aortic occlusion; no
montelukast administration) and G3 (45 min. aortic occlusion, 10 mg/kg montelukast
administration). At the 48^th hour of reperfusion, kidney and liver
samples were dissected for histopathological evaluation and immunohistochemical
staining for HSP70, interleukin-6 and myeloperoxidase (MPO).

 Results: Tissue
samples taken from the kidney showed significant intergroup differences in
terms of tubular cell degeneration, cytoplasmic vacuole formation, hemorrhage
and tubular dilatation (P = 0.001, P = 0.017, P = 0.001, P = 0.001
respectively). There was a significant difference with regards to HSP-70 stain
(P = 0.01) in favor of G1 and G3 with respect to G2. Hepatocyte degeneration in
the liver samples of G3 was significantly lower than that of G1 and G2 (P = 0.027).

 Conclusion: The
findings of the current study demonstrated that montelukast has protective
effects on both kidney and liver; and were confirmed   histopathologically and
immunohistochemically. The protective effects of montelukast can be attributed
to its potential of anti-oxidative and anti-inflammatory actions.

Keywords

Ischemia-reperfusion injury , montelukast , kidney , liver

Montelukastın karaciğer ve böbrekteki iskemi/reperfüzyon hasarına olan etkisi

Abstract

Amaç:
Torakoabdominal aort anevrizması cerrahisinin sebep olabildiği splanknik
iskemi, karaciğer ve/veya böbrek hasarının neden olduğu ciddi postoperatif
komplikasyonlarla sonuçlanabilir. Bu çalışmada seçici tersinir bir CysLT1
reseptör antagonisti olan montelukastın, aortanın geçici oklüzyonuyla yaratılan
böbrek ve karaciğer iskemi-reperfüzyon (I/R) hasarı üzerindeki koruyucu
etkisini incelemek için tasarlandı.

 Gereç ve Yöntemler: Yirmi bir
erkek Sprague-Dawley tipi sıçan, rasgele üç gruba (her grupta n=7) ayrıldı; G1
(aort oklüzyonu ve montelukast uygulaması yok), G2 (45 dakika aort oklüzyonu;
montelukast uygulması yok) ve G3 (45 dakika aort oklüzyonu, 10 mg/kg
montelukast uygulaması). Reperfüzyonun 48. saatinde böbrek ve karaciğerden
alınan doku örneklerinden histopatolojik değerlendirme ve HSP 70, interlökin-6
ve miyeloperoksidaz (MPO) ile immünohistokimyasal boyama yapıldı.

 Bulgular: Böbrekten
alınan doku örnekleri tübüler hücre dejenerasyonu, sitoplazmik vakuol formasyonu,
hemoraji ve tübüler dilatasyon açısındna incelendi ve gruplar arasında
istatistiksel olarak anlamlı fark bulundu (P = 0.001, P = 0.017, P = 0.001). G1
ve G3 gruplarında HSP-70 ile boyanmada G2 ye göre anlamlı fark saptandı (P = 0.001).
G3 karaciğer örneklerinde hepatosit dejenerasyonu G1 ve G2 den anlamlı olarak
düşüktü (P = 0.027).

 Sonuçlar:
Yapılan çalışmanın bulguları, montelukastın böbrek ve karaciğer üzerinde
koruyucu etkileri olduğunu histopatolojik ve immünohistokimyasal olarak
göstermiştir. Montelukastın koruyucu etkileri, ilacın antioksidan ve
antiinflamatuar etkilerine bağlanabilir. 

Keywords

İskemi-reperfüzyon injurisi , montelukast , böbrek , karaciğer

References

• 1. Welborn MB, Oldenburg HS, Hess PJ, et al. The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit Care Med 2000; 28: 3191-7.
• 2. Budak B, Seren M, Turan NN, Sakaogullari Z, Ulus AT. The protective effects of resveratrol and L-NAME on visceral organs following aortic clamping. Ann Vasc Surg 2009; 23: 675-85.
• 3. Walker PM. Ischemia/reperfusion injury in skeletal muscle. Ann Vasc Surg 1991; 5: 399-402.
• 4. Bown MJ, Nicholson ML, Bell PR, Sayers RD. Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2001; 22: 485-95.
• 5. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA. Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. The American journal of pathology 1993; 143: 453-63.
• 6. Bao XQ, Liu GT. Bicyclol: a novel antihepatitis drug with hepatic heat shock protein 27/70-inducing activity and cytoprotective effects in mice. Cell Stress Chaperones 2008; 13: 347-55.
• 7. Zhang K, Zhao T, Huang X, et al. Preinduction of HSP70 promotes hypoxic tolerance and facilitates acclimatization to acute hypobaric hypoxia in mouse brain. Cell Stress Chaperones 2009;14: 407-15.
• 8. Latchman DS. Heat shock proteins and cardiac protection. Cardiovasc Res 2001; 51: 637-46.
• 9. D DMosser, A W Caron, L Bourget, C Denis-Larose, B Massie. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 1997; 17: 5317-27.
• 10. Fujibayashi T, Hashimoto N, Jijiwa M, Hasegawa Y, Kojima T, Ishiguro N. Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model. BMC Pulm Med 2009; 9: 45.
• 11. Choudhury S, Bae S, Ke Q, Lee JY, Kim J, Kang PM. Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion. Basic Res Cardiol 2011; 106: 397-407.
• 12. Moreland DB, Soloniuk DS, Feldman MJ. Leukotrienes in experimental spinal cord injury. Surg Neurol 1989; 31: 277-80.
• 13. Sener G, Sehirli O, Velioğlu-Oğünç A, et al. Montelukast protects against renal ischemia/reperfusion injury in rats. Pharmacol Res 2006; 54: 65-71.
• 14. Damtew B, Marino JA, Fratianne RB, Spagnuolo PJ. Neutrophil lipoxygenase metabolism and adhesive function following acute thermal injury. J Lab Clin Med 1993; 121: 328-36.
• 15. Wallace JL, Beck PL, Morris GP. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage? Am J Physiol 1988; 254:G117-23.
• 16. Rashmitha N ST, Srinivas CH, Srinivas N, et al. A validated RP-HPLC method for the determination ofimpurities in montelukast sodium. EJ Chem 2010; 7: 555-63.
• 17. Gedik HS, Korkmaz K, Erdem H, Karakilic E, Lafci G, Ankarali H. Protective effect of heparin in the end organ ischemia/reperfusion injury of the lungs and heart. J Cardiothorac Surg 2012; 7: 123.
• 18. Korkmaz K, Gedik HS, Budak AB, et al. Effect of heparin on neuroprotection against spinal cord ischemia and reperfusion in rats. Eur Rev Med Pharmacol Sci 2013; 17: 522-30.
• 19. Umehara S, Goyagi T, Nishikawa T, Tobe Y, Masaki Y. Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats. AnesthAnalg. 2010; 110: 1133-7.
• 20. Yener AU, Ciçek MC, Genç SB, et al. Protective role of heparin in the injury of the liver and kidney on the experimental model of ischemia/reperfusion. J Cardiothorac Surg 2014; 9: 35.
• 21. Harward TR, Welborn MB 3rd, Martin TD, et al. Visceral ischemia and organ dysfunction after thoracoabdominal aortic aneurysm repair. A clinical and cost analysis. Ann Surg 1996; 223: 729-34.
• 22. Wang Z, Liu Y, Han Y, et al. Protective effects of aliskiren on ischemia-reperfusion-induced renal injury in rats. Eur J Pharmacol 2013; 718: 160-6.
• 23. Yildar M, Aksit H, Korkut O, Ozyigit MO, Sunay B, Seyrek K. Protective effect of 2-aminoethyl diphenylborinate on acute ischemia-reperfusion injury in the rat kidney. J Surg Res 2014; 187: 683-9.
• 24. Nicoud IB, Knox CD, Jones CM, et al. 2-APB protects against liver ischemia-reperfusion injury by reducing cellular and mitochondrial calcium uptake.Am J PhysiolGastrointest Liver Physiol 2007; 293: G623-30.
• 25. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
• 26. Peters-Golden M, Henderson WRJr.Leukotrienes. N Engl J Med 2007; 357: 1841-54.
• 27. Takamatsu Y, Shimada K, Chijiiwa K, Kuroki S, Yamaguchi K, Tanaka M. Role of leukotrienes on hepatic ischemia/reperfusion injury in rats. J Surg Res 2004; 119: 14-20.
• 28. Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 1991; 87: 2036-41.
• 29. Virchow JCJr, Faehndrich S, Nassenstein C, Bock S, Matthys H, Luttmann W. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. ClinExp Allergy 2001; 31: 836-44.
• 30. Anderson R, Theron AJ, Gravett CM, Steel HC, Tintinger GR, Feldman C. Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism. Br J Pharmacol 2009; 156: 105-15.
• 31. Cambria RP, Clouse WD, Davison JK, Dunn PF, Corey M, Dorer D. Thoracoabdominal aneurysm repair: results with 337 operations performed over a 15-year interval. Ann Surg 2002; 236: 471-9.
• 32. Jacobs MJ, van Eps RG, de Jong DS, Schurink GW, Mochtar B. Prevention of renal failure in patients undergoing thoracoabdominal aortic aneurysm repair. J Vasc Surg 2004; 40: 1067-73.
• 33. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Thoracoabdominal aortic aneurysms associated with celiac, superior mesenteric, and renal artery occlusive disease: methods and analysis of results in 271 patients. J Vasc Surg 1992; 16: 378-89.
• 34. Adembri G, Kastamoniti E, Bertolozzi I, et al. Pulmonary ınjury follows systemic ınflamatory reaction in ınfrarenal aortic surgery. Crit Care Med 2004; 9: 1170-7.
• 35. Norwood MG, Bown MJ, Sutton AJ, Nicholson ML, Sayers RD. Interleukin 6 production during abdominal aortic aneurysm repair arises from the gastrointestinal tract and not the legs. Br J Surg 2004; 9: 1153-6.
• 36. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Immunology 2001; 102: 53-8.
• 37. Lauriat S, Linas SL. The role of neutrophils in acute renal failure. SeminNephrol 1998; 18: 498-504.
• 38. Ellis RJ, van der Vies SM. Molecular chaperones. Annu Rev Biochem 1991; 60: 321-47.
• 39. Hartl FU, Martin J, Neupert W. Protein folding in the cell: the role of molecular chaperones Hsp70 and Hsp60. Annu Rev Biophys Biomol Struct 1992;21: 293-322.
• 40. Pan LJ, Zhang ZC, Zhang ZY, et al. Effects and mechanisms of store-operated calcium channel blockade on hepatic ischemia-reperfusion injury in rats. World J Gastroenterol 2012; 18: 356-67.
• 41. Dawson TL, Gores GJ, Nieminen AL, Herman B, Lemasters JJ. Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am J Physiol 1993; 264: C961-7.
• 42. Kadkhodaee M, Golab F, Zahmatkesh M, Ghaznavi R, Hedayati M, Arab HA, Ostad SN, Soleimani M. Effects of different periods of renal ischemia on liver as a remote organ. World J Gastroenterol 2009; 15: 1113-8.
• 43. Kaçmaz A, User EY, Sehirli AO, Tilki M, Ozkan S, Sener G. Protective effect of melatonin against ischemia/reperfusion-induced oxidative remote organ injury in the rat. Surg Today 2005; 35: 744-50.
• 44. Awad AS, Kamel R, Sherief MA. Effect of thymoquinone on hepatorenal dysfunction and alteration of CYP3A1 and spermidine/spermine N-1-acetyl-transferase gene expression induced by renal ischaemia-reperfusion in rats. J Pharm Pharmacol 2011; 63: 1037-42.